INOVIO and Akeso Partner to Study New Glioblastoma Therapy
PLYMOUTH MEETING, PA — INOVIO and Akeso, Inc. announced a clinical trial collaboration to evaluate a combination immunotherapy as a potential treatment for Glioblastoma, the most common and aggressive form …
INOVIO and Akeso Partner to Study New Glioblastoma Therapy Read More